Dr. Ahmad shares what’s ahead, including the Facial & Rhinoplasty Symposium in Boca Raton, registration opening this month for The Aesthetic MEET 2027 in Miami Beach, and important updates to the way the Society connects and engages with members.
During Breast Cancer Awareness Month, The Aesthetic Foundation is highlighting the various ways that our members and donors are making an impact on patients and the specialty.
This year's cruise was our largest since 2007, with more than 150 cabins sold and over 320 attendees, including spouses, families, and guests. Among them were 120 registered plastic surgeons, including 15 current and past leaders of both the Society and Foundation. Our faculty featured 37 distinguished subject matter experts, eight of whom were first-time cruise speakers, and attendees represented ten different countries.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”